Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis

Shasha Rao, Clive Prestidge, Lynn Miesel, Deb Sweeney, L Shinabarger, Ramiz Boulos

    Research output: Contribution to journal › Article › peer-review

    19 Citations (Scopus)
    28 Downloads (Pure)

    Fingerprint

    Dive into the research topics of 'Preclinical development of Ramizol, an antibiotic belonging to a new class, for the treatment of Clostridium difficile colitis'. Together they form a unique fingerprint.

    Pharmacology, Toxicology and Pharmaceutical Science

    Immunology and Microbiology